F. Strassheimer

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

S. König, T. Tonn, L. Sevenich, 2022, Oncoimmunology.

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

W. Wels, J. Steinbach, T. Tonn, 2019, Front. Immunol..

P06.12 Combination therapy of CAR-NK-cells and anti-PD-1 antibody results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo

T. Tonn, L. Sevenich, Y. Reiss, 2020 .

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

P. Oefner, U. Hofmann, J. Steinbach, 2020, Cancers.

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase

R. Savai, O. Timofeev, T. Stiewe, 2022, Molecular Cancer.

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

K. Langen, E. Hattingen, W. Wels, 2023, Neuro-oncology.